Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Bullboard Posts
Comment by GoldMan22on Aug 01, 2010 11:08am
446 Views
Post# 17313809

RE: A DEAL, ... ....!

RE: A DEAL, ... ....!Oh noooooooooooooooooooooooooooooooo!!!!!

Pinetree dumping shares!

Jul 30/10 Jul 22/10 Pinetree Capital Ltd. Indirect Ownership Common Shares 10 - Disposition in the public market -21,000
.250
Jul 30/10 Jul 21/10 Pinetree Capital Ltd. Indirect Ownership Common Shares 10 - Disposition in the public market -58,500
.250
Jul 28/10 Jul 20/10 Pinetree Capital Ltd. Indirect Ownership Common Shares 10 - Disposition in the public market -141,500
.252
Jul 28/10 Jul 16/10 Pinetree Capital Ltd. Indirect Ownership Common Shares 10 - Disposition in the public market -34,000
.250
Jul 23/10 Jul 22/10 Inwentash, Sheldon Control or Direction Common Shares 10 - Disposition in the public market -21,000
.250
Jul 22/10 Jul 21/10 Inwentash, Sheldon Control or Direction Common Shares 10 - Disposition in the public market -58,500
.250
Jul 21/10 Jul 20/10 Inwentash, Sheldon Control or Direction Common Shares 10 - Disposition in the public market -141,500
.252
Jul 21/10 Jul 16/10 Inwentash, Sheldon Control or Direction Common Shares 10 - Disposition in the public market -34,000
.250
Bullboard Posts